Many studies have reported that insulin sensitizers improve insulin resistance and reduce high androgen levels, subsequently ameliorating ovulation disorders in women with PCOS [8–10]; in particular, use of metformin has become common [11, 12]. The gene discussed is INS; the disease is polycystic ovary syndrome.